• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln104Ter (c.310C>T); ClinVar=VCV000566924; Zygosity=Homozygous (PubMed=29970484; PubMed=33802339).
  

PubMed=16715129; DOI=10.1038/sj.onc.1209690
Anna-Kaarina Jarvinen, Reija Autio, Saija Haapa-Paananen, Maija Wolf, Matti Saarela, Reidar Grenman, Ilmo Leivo, Olli-Pekka Kallioniemi, Antti A. Makitie, Outi Monni;
Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses.
Oncogene 25:6997-7008(2006)

PubMed=17312569; DOI=10.1002/hed.20478
Charles J. Lin, Jennifer Rubin Grandis, Thomas E. Carey, Susanne M. Gollin, Theresa L. Whiteside, Wayne M. Koch, Robert Louis Ferris, Stephen Y. Lai;
Head and neck squamous cell carcinoma cell lines: established models and rationale for selection.
Head Neck 29:163-188(2007)

PubMed=26694163; DOI=10.1371/journal.pone.0144924; PMCID=PMC4692263
Joanna Janiszewska, Marcin Szaumkessel, Magdalena Kostrzewska-Poczekaj, Kinga Bednarek, Julia Paczkowska, Joanna Jackowska, Reidar Grenman, Krzysztof Szyfter, Malgorzata Wierzbicka, Maciej Giefing, Malgorzata Jarmuz-Szymczak;
Global miRNA expression profiling identifies miR-1290 as novel potential oncomiR in laryngeal carcinoma.
PLoS ONE 10:e0144924.1-e0144924.13(2015)

PubMed=29970484; DOI=10.1158/1535-7163.MCT-17-0733
Tatiana Lepikhova, Piia-Riitta Karhemo, Riku Louhimo, Bhagwan Yadav, Astrid Murumagi, Evgeny Kulesskiy, Mikko Kivento, Harri Sihto, Reidar Grenman, Stina M. Syrjanen, Olli-Pekka Kallioniemi ...Show all 15 authors... , Tero Aittokallio, Krister Wennerberg, Heikki Joensuu, Outi Monni; Show fewer authors
Drug-sensitivity screening and genomic characterization of 45 HPV-negative head and neck carcinoma cell lines for novel biomarkers of drug efficacy.
Mol. Cancer Ther. 17:2060-2071(2018)

PubMed=33802339; DOI=10.3390/cancers13051069; PMCID=PMC7959143
Eva-Leonne Gottgens, Marleen Ansems, William P.J. Leenders, Johan Bussink, Paul N. Span;
Genotyping and characterization of HPV status, hypoxia, and radiosensitivity in 22 head and neck cancer cell lines.
Cancers (Basel) 13:1069.1-1069.12(2021)